The clinical importance of DYRK1A downregulation is supported by reports indicating that DYRK1A mutations are found in 0.1–0.5% of individuals with ASD and/or intellectual disability [4–6, 9–12] and ~0.5% of those with developmental disorders [13]. Here, DYRK1A is linked to Intellectual disability.